- Release Date: 16/08/22 09:45
- Summary: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
- Price Sensitive: Yes
- Download Document 155.53KB
- Forums
- ASX - By Stock
- EMD
- Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.69M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.9¢ | $5.163K | 105K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 38827 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.050 |
3 | 215869 | 0.049 |
1 | 25006 | 0.048 |
1 | 11000 | 0.047 |
1 | 200000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 38827 | 1 |
0.052 | 65193 | 1 |
0.053 | 10000 | 1 |
0.062 | 51000 | 1 |
0.064 | 125693 | 2 |
Last trade - 15.00pm 03/05/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |